Hyperkeratosis-hyperpigmentation syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1336OMIM:144190Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hyperkeratosis-hyperpigmentation syndrome is an extremely rare genetic skin condition. The name describes its two main features: hyperkeratosis, which means the outer layer of skin becomes unusually thick and rough, and hyperpigmentation, which means patches of skin become darker than normal. This condition typically affects the skin from an early age and can involve widespread areas of the body. People with this syndrome may notice thickened, scaly patches of skin along with areas of dark discoloration. The severity can vary from person to person. In some cases, the thickened skin may appear on the palms of the hands and soles of the feet (a feature called palmoplantar keratoderma), and darkened patches may be found on the trunk, limbs, or other body areas. The condition is classified under other specified congenital malformations of the skin (ICD-10 code Q82.8). Because this syndrome is so rare, there is no specific cure. Treatment is mainly supportive and focuses on managing symptoms. Moisturizers, keratolytic creams (which help soften and remove thickened skin), and sun protection may be recommended. Dermatologists and clinical geneticists are the primary specialists involved in care. Research into the exact genetic cause and better treatments is still ongoing, and much remains to be learned about this condition.

Key symptoms:

Thickened, rough patches of skinDark patches or spots on the skinScaly or flaky skinThickened skin on palms and solesDry skinUneven skin colorSkin that may feel bumpy or texturedPossible nail changes

Clinical phenotype terms (5)— hover any for plain English
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hyperkeratosis-hyperpigmentation syndrome.

View clinical trials →

No actively recruiting trials found for Hyperkeratosis-hyperpigmentation syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hyperkeratosis-hyperpigmentation syndrome community →

No specialists are currently listed for Hyperkeratosis-hyperpigmentation syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hyperkeratosis-hyperpigmentation syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hyperkeratosis-hyperpigmentation syndromeForum →

No community posts yet. Be the first to share your experience with Hyperkeratosis-hyperpigmentation syndrome.

Start the conversation →

Latest news about Hyperkeratosis-hyperpigmentation syndrome

No recent news articles for Hyperkeratosis-hyperpigmentation syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the likely cause of my (or my child's) skin changes?,Is genetic testing recommended, and what might it tell us?,What skin care routine do you recommend for managing the thickened skin and dark patches?,Are there any prescription creams or treatments that could help?,Could this condition get worse over time, or does it tend to stay stable?,Should we see a genetic counselor to understand the chances of passing this to future children?,Are there any clinical trials or new treatments being studied for this condition?

Common questions about Hyperkeratosis-hyperpigmentation syndrome

What is Hyperkeratosis-hyperpigmentation syndrome?

Hyperkeratosis-hyperpigmentation syndrome is an extremely rare genetic skin condition. The name describes its two main features: hyperkeratosis, which means the outer layer of skin becomes unusually thick and rough, and hyperpigmentation, which means patches of skin become darker than normal. This condition typically affects the skin from an early age and can involve widespread areas of the body. People with this syndrome may notice thickened, scaly patches of skin along with areas of dark discoloration. The severity can vary from person to person. In some cases, the thickened skin may appear

At what age does Hyperkeratosis-hyperpigmentation syndrome typically begin?

Typical onset of Hyperkeratosis-hyperpigmentation syndrome is childhood. Age of onset can vary across affected individuals.